You are here: Industry Insights > Glenmark

News List

Glenmark forays into branded dermatology segment in US expressbpd
December 20, 2018
The branded portfolio for the US market will be developed and commercialised by Glenmark Therapeutics USA
Glenmark Pharmaceuticals receives ANDA approval for Fluocinolone Acetonide Oil expressbpd
December 19, 2018
Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio
Glenmark receives ANDA approval for Hydrocortisone Valerate Ointment expressbpd
December 17, 2018
The company is eligible for 180 days of CGT exclusivity upon commercialisation
Glenmark gets US FDA nod for generic acne treatment gel expressbpd
November 21, 2018
The approval granted is for Azelaic Acid Gel, 15 per cent, which is a generic version of Finacea Gel (15 per cent) of Leo Pharma
Glenmark gets US FDA nod for generic acne treatment gel expressbpd
November 20, 2018
Citing market data, the company said for the 12-month period ended September 2018, Finacea Gel (15 per cent ) achieved annual sales of approximately $ 64.1 million.
Glenmark Launches CD38xCD3 Phase 1 Trial for Bispecific Antibody GBR 1342 americanpharmaceuticalreview
November 10, 2018
Glenmark Pharmaceuticals announced the decision to launch a Phase 1 trial in solid tumors for its CD38xCD3 bispecific antibody GBR 1342. The decision is driven by recent findings derived from a non-interventional human study utilizing a clinically validat
Glenmark Opens First U.S. Mfg. Site contractpharma
November 01, 2018
Glenmark Opens First U.S. Mfg. Site
Glenmark gets USFDA nod for generic Derma-Smoothe Topical Oil glenmark
October 31, 2018
Glenmark Pharmaceuticals received final approval from the US health regulator for generic version of Derma-Smoothe Topical Oil, used in the treatment of scalp psoriasis.
Glenmark Pharma considers buyback of Singapore FCCBs biospectrumasia
October 11, 2018
Glenmark Pharma said its operations committee would consider opportunistic tenders or buybacks of any part of its Singapore listed foreign currency convertible bonds
Glenmark inks pact with True North for pain management biospectrumasia
August 13, 2018
The business is valued at Rs 6.35 bn and Glenmark will continue to hold a stake in the new company

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page